Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

KRTAP1-4 Inhibitors

KRTAP1-4 inhibitors are a class of chemical compounds that target the Keratin-associated proteins (KRTAP), particularly the subfamily members KRTAP1 through KRTAP4. These proteins are involved in the regulation of keratin intermediate filament organization, which plays a key role in maintaining the structural integrity of epithelial cells. Inhibitors of KRTAP1-4 typically function by disrupting the molecular interactions between keratins and their associated proteins, leading to alterations in the dynamics of keratin filament assembly. The structural diversity of these inhibitors can range from small molecules to peptides, with specific binding affinities for the KRTAP1-4 subfamily. This specificity is largely attributed to the unique binding motifs and conformations present within these proteins, allowing for selective inhibition that minimizes off-target interactions with other keratin-associated proteins.

Mechanistically, KRTAP1-4 inhibitors act by influencing the phosphorylation state, protein-protein interactions, or post-translational modifications of keratin filaments. These effects lead to modifications in the cytoskeletal architecture, potentially altering cellular processes such as migration, adhesion, and differentiation. The precise molecular targets of these inhibitors can vary, depending on the structural features of the compound and the specific KRTAP family member it targets. In biochemical studies, KRTAP1-4 inhibitors are often employed to investigate the regulatory pathways governing keratin network organization, as well as to study the role of these proteins in cellular resilience to mechanical stress. Understanding the molecular basis of KRTAP1-4 inhibition is critical for dissecting the complexities of keratin function and the broader cytoskeletal systems in which they are embedded.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Inhibits eukaryotic protein synthesis, potentially reducing KRTAP1-4 levels.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Prevents proteasomal degradation, which can influence KRTAP1-4 stability.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Interferes with DNA-dependent RNA synthesis, possibly affecting KRTAP1-4 transcription.

Puromycin dihydrochloride

58-58-2sc-108071
sc-108071B
sc-108071C
sc-108071A
25 mg
250 mg
1 g
50 mg
$42.00
$214.00
$832.00
$66.00
394
(15)

Causes premature termination of protein translation, possibly leading to reduced KRTAP1-4 synthesis.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Inhibits lysosomal degradation, potentially affecting the turnover of KRTAP1-4.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor that can decrease protein synthesis, potentially lowering KRTAP1-4 levels.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Inhibits the proteasome, potentially increasing KRTAP1-4 levels due to reduced degradation.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

Inhibits RNA polymerase II, potentially decreasing KRTAP1-4 mRNA production.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Inhibits histone deacetylases, potentially affecting KRTAP1-4 gene expression.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$39.00
$59.00
$104.00
$206.00
8
(1)

Binds to Hsp90, which can affect the folding and function of client proteins, including potentially KRTAP1-4.